1. CXCR1 knockdown improves the sensitivity of osteosarcoma to cisplatin
   Xiu-guo Han et al, 2015, Cancer Letters CrossRef
2. Podocalyxin promotes proliferation and survival in mature B-cell non-Hodgkin lymphoma cells
   Estíbaliz Tamayo-Orbegozo et al, 2017, Oncotarget CrossRef
3. Podocalyxin promotes the formation of compact and chemoresistant cancer spheroids in high grade serous carcinoma
   Ngoc Le Tran et al, 2024, Scientific Reports CrossRef
4. Silencing LPAATβ inhibits tumor growth of cisplatin-resistant human osteosarcoma in vivo and in vitro
   Lei Song et al, 2017, International Journal of Oncology CrossRef
5. Emerging Role of Podocalyxin in the Progression of Mature B-Cell Non-Hodgkin Lymphoma
   Estíbaliz Tamayo-Orbegozo et al, 2020, Cancers CrossRef
6. Expression of podocalyxin-like protein is an independent prognostic biomarker in resected esophageal and gastric adenocarcinoma
   David Borg et al, 2016, BMC Clinical Pathology CrossRef
7. Impact of histological response after neoadjuvant therapy on podocalyxin as a prognostic marker in pancreatic cancer
   Annika Eurola et al, 2021, Scientific Reports CrossRef
8. The Lectin LecB Induces Patches with Basolateral Characteristics at the Apical Membrane to Promote Pseudomonas aeruginosa Host Cell Invasion
   Roland Thuenauer et al, 2022, mBio CrossRef
9. Podocalyxin-like protein as a predictive biomarker for benefit of neoadjuvant chemotherapy in resectable gastric and esophageal adenocarcinoma
   David Borg et al, 2018, Journal of Translational Medicine CrossRef
10. miR-1182 inhibits growth and mediates the chemosensitivity of bladder cancer by targeting hTERT
    Jun Zhou et al, 2016, Biochemical and Biophysical Research Communications CrossRef
11. Podocalyxin in Normal Tissue and Epithelial Cancer
    Ngoc Le Tran et al, 2021, Cancers CrossRef
12. Multifaceted role of RNA editing in promoting loss-of-function of PODXL in cancer
    Ting Fu et al, 2022, iScience CrossRef